Quantitative serum tumor markers (CEA, CA19-9, and CA-125) are independently predictive of survival in patients with appendiceal adenocarcinoma

被引：0
|
作者：
Shen, J. P. Y-C. [1 ]
Yousef, A. [1 ]
Yousef, M. M. G. [1 ]
Zeineddine, M. [1 ]
Chowdhury, S. [1 ]
Knafl, M. [2 ]
Raghav, K. [1 ]
White, M. G. [3 ]
Alfaro-Munoz, K. [1 ]
Helmink, B. [4 ]
Fournier, K. F. [4 ]
Overman, M. J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Colon & Rectal Surg, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Surg Oncol, Houston, TX USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2914
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
190P
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [31] Serum CEA, CA125, CA19-9, and CA724 levels for the diagnosis and staging of cholangiocarcinoma.
    Deng, Yawen
    Zhong, Rihui
    Xie, Xiaoying
    Xiong, Xuxia
    He, Jian
    Peng, Linhui
    Zeng, Hua
    Duan, Chaohui
    [J]. BIOMEDICAL RESEARCH-INDIA, 2017, 28 (03): : 1413 - 1418
  • [32] Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?
    Hasbahceci, M.
    Malya, F. U.
    Kunduz, E.
    Guler, M.
    Unver, N.
    Akcakaya, A.
    [J]. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2018, 100 (04) : 257 - 266
  • [33] Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei
    Nummela, Pirjo
    Leinonen, Hannele
    Jarvinen, Petrus
    Thiel, Alexandra
    Jarvinen, Heikki
    Lepisto, Anna
    Ristimaki, Ari
    [J]. HUMAN PATHOLOGY, 2016, 54 : 47 - 54
  • [34] Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma
    Wang, Zi
    Tian, Ya-Ping
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 265 - 268
  • [35] Diagnostic role of tumour markers CEA, CA15-3, CA19-9 and CA125 in lung cancer
    Ghosh I.
    Bhattacharjee D.
    Das A.K.
    Chakrabarti G.
    Dasgupta A.
    Dey S.K.
    [J]. Indian Journal of Clinical Biochemistry, 2013, 28 (1) : 24 - 29
  • [36] CEA, CA-19-9 AND CA-125 IN ASCITES-FLUID FROM CANCER-PATIENTS
    BHARGAVA, A
    PETRELLI, N
    PIVER, S
    NEMOTO, T
    DOUGLASS, H
    TAKITA, H
    KAE, L
    BROWN, W
    FITZPATRICK, J
    [J]. CLINICAL CHEMISTRY, 1986, 32 (06) : 1122 - 1122
  • [37] CEA and CA19-9 and their Association with Overall Survival in Patients with a gastroesophageal Tumor - a retrospective Data Analysis
    Kuchling, D. A.
    Jomrich, G.
    Paireder, M.
    Schoppmann, S. F.
    Berghoff, A. S.
    Preusser, M.
    Ilhan-Mutlu, A.
    Puhr, H. C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 223 - 223
  • [38] Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9
    Gao, Y. -C.
    Yuan, Z. -B.
    Yang, Y. -D.
    Lu, H. -K.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (07): : 741 - 747
  • [39] SENSITIVITY AND SPECIFICITY OF CA19-9 AND CEA TUMOR ASSAYS IN PATIENTS WITH HYPERBILIRUBINEMIA
    STEINBERG, WM
    GELFAND, R
    ANDERSON, KK
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (10) : 970 - 970
  • [40] Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
    Fang, Tianyi
    Wang, Hao
    Wang, Yufu
    Lin, Xuan
    Cui, Yunfu
    Wang, Zhidong
    [J]. DISEASE MARKERS, 2019, 2019
12345